Status:

UNKNOWN

Blood Transfusion Among Patients With Pelvic Fracture in China

Lead Sponsor:

The Third Xiangya Hospital of Central South University

Collaborating Sponsors:

Beijing Shijitan Hospital, Capital Medical University

The Affiliated Hospital Of Southwest Medical University

Conditions:

Pelvic Fracture

Transfusion Reaction

Eligibility:

All Genders

1-80 years

Brief Summary

According to the patient's blood management concept, this study intends to collect basic information, surgical data, blood transfusion related data and patient prognosis data of patients with pelvic f...

Detailed Description

2.1 Research Objectives: This study aims to construct a blood transfusion model for pelvic fractures, to guide the rational use of blood during surgery, and to improve the prognosis of patients. 2.2 ...

Eligibility Criteria

Inclusion

  • (1) 1\<Age\<80, and Chinese residents living in China more than 3 years;
  • (2) Hemoglobin value less than 100g/L during hospitalization;

Exclusion

  • (1) Participants who suffered from pelvic fracture within 3 months
  • (2) Participants who suffer from pathological fractures of the pelvis caused by malignant tumors
  • (3) Participants with chronic anemia and coagulopathy
  • (4) Participants who rufuse blood transfusion

Key Trial Info

Start Date :

April 5 2019

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

September 1 2019

Estimated Enrollment :

2000 Patients enrolled

Trial Details

Trial ID

NCT03855644

Start Date

April 5 2019

End Date

September 1 2019

Last Update

February 27 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Third Xiangya Hospital

Changsha, Hunan, China, 410013